论文部分内容阅读
目的:试论特步他林、布地奈德在支气管哮喘急性发作治疗中的疗效观察。方法:选取2014年7月到2015年7月我院收治的支气管哮喘急性发作患者30例作为对照组,仅给予特步他林治疗;选取同期同类型患者30例作为研究组,给予特步他林联合布地奈德治疗。对两组患者的临床治疗效果进行分析和对比。结果:给予两种不同的治疗方法后,研究组治疗总体有效率显著高于对照组(P<0.05),有统计学意义。讨论:对支气管哮喘急性发作患者采用特步他林、布地奈德治疗方法,效果显著,值得在临床医学上大力推广使用。
Objective: To observe the effect of tebutrine and budesonide in the treatment of acute attack of bronchial asthma. Methods: Thirty patients with acute exacerbation of bronchial asthma admitted to our hospital from July 2014 to July 2015 were selected as the control group and treated with Xteptaralin only. Thirty patients of the same type were selected as the study group, Budesonide treatment. The clinical effects of two groups of patients were analyzed and compared. Results: After giving two different treatment methods, the total effective rate of the study group was significantly higher than that of the control group (P <0.05), with statistical significance. Discussion: In patients with acute exacerbation of bronchial asthma using tebutrine, budesonide treatment, the effect is significant, it is worth to promote the use of clinical medicine.